All news
AI

Finding New Drugs Is Laborious. This AI Startup Is Skipping The Lab Work

Wired

Potential Sciences, a startup backed by the UK government, is betting that training AI models on computer-generated biochemical data can speed up the plodding process of developing new drugs. A new British startup believes that artificial intelligence is the key to speedrunning the slow and temperamental process of drug design.

Summary drawn from Wired's own description of the story.

All tech news
Loading related stories